Discovery of orally bioavailable 1,3,4-trisubstituted 2-oxopiperazine-based melanocortin-4 receptor agonists as potential antiobesity agents.

Xinrong Tian; Adrian G Switzer; Steve A Derose; Rajesh K Mishra; Mark G Solinsky; Rashid N Mumin; Frank H Ebetino; Lalith R Jayasinghe; Mark E Webster; Anny-Odile Colson

doi:10.1021/jm800525p

Discovery of orally bioavailable 1,3,4-trisubstituted 2-oxopiperazine-based melanocortin-4 receptor agonists as potential antiobesity agents.

Identifier:nobleid.org/w1/20260515/CD0EB2CF

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/CD0EB2CF.svg?ark=w1%2F20260515%2FCD0EB2CF)](https://nobleid.org/work/w1/20260515/CD0EB2CF)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Discovery of orally bioavailable 1,3,4-trisubstituted 2-oxopiperazine-based melanocortin-4 receptor agonists as potential antiobesity agents.

Identifier:nobleid.org/w1/20260515/CD0EB2CF

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/CD0EB2CF.svg?ark=w1%2F20260515%2FCD0EB2CF)](https://nobleid.org/work/w1/20260515/CD0EB2CF)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work